Global Olanzapine Market Growth 2025-2031

January 2025 | 107 pages | ID: G18B5198DF4EN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The report requires updating with new data and is sent in 48 hours after order is placed.

The global Olanzapine market size is predicted to grow from US$ 197 million in 2025 to US$ 226 million in 2031; it is expected to grow at a CAGR of 2.3% from 2025 to 2031.

Olanzapine is an atypical antipsychotic drugs, it is suitable for schizophrenia and other severe positive symptoms (for example: delusions, hallucinations, thought disorder, hostility and suspicion) and / or negative symptoms (such as: apathy acute and maintenance treatment, emotional and social withdrawal, poverty of speech) psychosis. In this report, we research and analyze the olanzapine, which used for manufacturing the olanzapine tablets.

Global Olanzapine key players include Lilly, Teva Pharmaceutical, Dr. Reddy's Laboratories, Apotex Inc, Hansoh Pharmaceutical, etc. Global top five manufacturers hold a share over 85%.

North America is the largest market, with a share over 70%, followed by Asia, which has a share over 25%.

In terms of product, Patent is the largest segment, with a share about 55%. And in terms of application, the largest application is Olanzapine Tablets, followed by Daily Commodities, etc.

LP Information, Inc. (LPI) ' newest research report, the “Olanzapine Industry Forecast” looks at past sales and reviews total world Olanzapine sales in 2024, providing a comprehensive analysis by region and market sector of projected Olanzapine sales for 2025 through 2031. With Olanzapine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Olanzapine industry.

This Insight Report provides a comprehensive analysis of the global Olanzapine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Olanzapine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Olanzapine market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Olanzapine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Olanzapine.

This report presents a comprehensive overview, market shares, and growth opportunities of Olanzapine market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
  • Patent
  • Generics
Segmentation by Application:
  • Olanzapine Tablets
  • Others
This report also splits the market by region:
  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
  • Lilly
  • Teva Pharmaceutical
  • Dr. Reddy's Laboratories
  • Apotex Inc.
  • Mylan Pharmaceuticals
  • Par Pharmaceutical
  • Aurobindo Pharma
  • Torrent Pharmaceuticals
  • Jubilant Lifesciences
  • Sun Pharmaceutical
  • Sandoz
  • Hansoh Pharmaceutical
  • WATSON Pharmaceuticals(Changzhou)
  • Zhejiang Langhua Pharmaceuticals
Key Questions Addressed in this Report

What is the 10-year outlook for the global Olanzapine market?

What factors are driving Olanzapine market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Olanzapine market opportunities vary by end market size?

How does Olanzapine break out by Type, by Application?
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Olanzapine Annual Sales 2020-2031
  2.1.2 World Current & Future Analysis for Olanzapine by Geographic Region, 2020, 2024 & 2031
  2.1.3 World Current & Future Analysis for Olanzapine by Country/Region, 2020, 2024 & 2031
2.2 Olanzapine Segment by Type
  2.2.1 Patent
  2.2.2 Generics
2.3 Olanzapine Sales by Type
  2.3.1 Global Olanzapine Sales Market Share by Type (2020-2025)
  2.3.2 Global Olanzapine Revenue and Market Share by Type (2020-2025)
  2.3.3 Global Olanzapine Sale Price by Type (2020-2025)
2.4 Olanzapine Segment by Application
  2.4.1 Olanzapine Tablets
  2.4.2 Others
2.5 Olanzapine Sales by Application
  2.5.1 Global Olanzapine Sale Market Share by Application (2020-2025)
  2.5.2 Global Olanzapine Revenue and Market Share by Application (2020-2025)
  2.5.3 Global Olanzapine Sale Price by Application (2020-2025)

3 GLOBAL BY COMPANY

3.1 Global Olanzapine Breakdown Data by Company
  3.1.1 Global Olanzapine Annual Sales by Company (2020-2025)
  3.1.2 Global Olanzapine Sales Market Share by Company (2020-2025)
3.2 Global Olanzapine Annual Revenue by Company (2020-2025)
  3.2.1 Global Olanzapine Revenue by Company (2020-2025)
  3.2.2 Global Olanzapine Revenue Market Share by Company (2020-2025)
3.3 Global Olanzapine Sale Price by Company
3.4 Key Manufacturers Olanzapine Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Olanzapine Product Location Distribution
  3.4.2 Players Olanzapine Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR OLANZAPINE BY GEOGRAPHIC REGION

4.1 World Historic Olanzapine Market Size by Geographic Region (2020-2025)
  4.1.1 Global Olanzapine Annual Sales by Geographic Region (2020-2025)
  4.1.2 Global Olanzapine Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Olanzapine Market Size by Country/Region (2020-2025)
  4.2.1 Global Olanzapine Annual Sales by Country/Region (2020-2025)
  4.2.2 Global Olanzapine Annual Revenue by Country/Region (2020-2025)
4.3 Americas Olanzapine Sales Growth
4.4 APAC Olanzapine Sales Growth
4.5 Europe Olanzapine Sales Growth
4.6 Middle East & Africa Olanzapine Sales Growth

5 AMERICAS

5.1 Americas Olanzapine Sales by Country
  5.1.1 Americas Olanzapine Sales by Country (2020-2025)
  5.1.2 Americas Olanzapine Revenue by Country (2020-2025)
5.2 Americas Olanzapine Sales by Type (2020-2025)
5.3 Americas Olanzapine Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Olanzapine Sales by Region
  6.1.1 APAC Olanzapine Sales by Region (2020-2025)
  6.1.2 APAC Olanzapine Revenue by Region (2020-2025)
6.2 APAC Olanzapine Sales by Type (2020-2025)
6.3 APAC Olanzapine Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Olanzapine by Country
  7.1.1 Europe Olanzapine Sales by Country (2020-2025)
  7.1.2 Europe Olanzapine Revenue by Country (2020-2025)
7.2 Europe Olanzapine Sales by Type (2020-2025)
7.3 Europe Olanzapine Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Olanzapine by Country
  8.1.1 Middle East & Africa Olanzapine Sales by Country (2020-2025)
  8.1.2 Middle East & Africa Olanzapine Revenue by Country (2020-2025)
8.2 Middle East & Africa Olanzapine Sales by Type (2020-2025)
8.3 Middle East & Africa Olanzapine Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Olanzapine
10.3 Manufacturing Process Analysis of Olanzapine
10.4 Industry Chain Structure of Olanzapine

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Olanzapine Distributors
11.3 Olanzapine Customer

12 WORLD FORECAST REVIEW FOR OLANZAPINE BY GEOGRAPHIC REGION

12.1 Global Olanzapine Market Size Forecast by Region
  12.1.1 Global Olanzapine Forecast by Region (2026-2031)
  12.1.2 Global Olanzapine Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Olanzapine Forecast by Type (2026-2031)
12.7 Global Olanzapine Forecast by Application (2026-2031)

13 KEY PLAYERS ANALYSIS

13.1 Lilly
  13.1.1 Lilly Company Information
  13.1.2 Lilly Olanzapine Product Portfolios and Specifications
  13.1.3 Lilly Olanzapine Sales, Revenue, Price and Gross Margin (2020-2025)
  13.1.4 Lilly Main Business Overview
  13.1.5 Lilly Latest Developments
13.2 Teva Pharmaceutical
  13.2.1 Teva Pharmaceutical Company Information
  13.2.2 Teva Pharmaceutical Olanzapine Product Portfolios and Specifications
  13.2.3 Teva Pharmaceutical Olanzapine Sales, Revenue, Price and Gross Margin (2020-2025)
  13.2.4 Teva Pharmaceutical Main Business Overview
  13.2.5 Teva Pharmaceutical Latest Developments
13.3 Dr. Reddy's Laboratories
  13.3.1 Dr. Reddy's Laboratories Company Information
  13.3.2 Dr. Reddy's Laboratories Olanzapine Product Portfolios and Specifications
  13.3.3 Dr. Reddy's Laboratories Olanzapine Sales, Revenue, Price and Gross Margin (2020-2025)
  13.3.4 Dr. Reddy's Laboratories Main Business Overview
  13.3.5 Dr. Reddy's Laboratories Latest Developments
13.4 Apotex Inc.
  13.4.1 Apotex Inc. Company Information
  13.4.2 Apotex Inc. Olanzapine Product Portfolios and Specifications
  13.4.3 Apotex Inc. Olanzapine Sales, Revenue, Price and Gross Margin (2020-2025)
  13.4.4 Apotex Inc. Main Business Overview
  13.4.5 Apotex Inc. Latest Developments
13.5 Mylan Pharmaceuticals
  13.5.1 Mylan Pharmaceuticals Company Information
  13.5.2 Mylan Pharmaceuticals Olanzapine Product Portfolios and Specifications
  13.5.3 Mylan Pharmaceuticals Olanzapine Sales, Revenue, Price and Gross Margin (2020-2025)
  13.5.4 Mylan Pharmaceuticals Main Business Overview
  13.5.5 Mylan Pharmaceuticals Latest Developments
13.6 Par Pharmaceutical
  13.6.1 Par Pharmaceutical Company Information
  13.6.2 Par Pharmaceutical Olanzapine Product Portfolios and Specifications
  13.6.3 Par Pharmaceutical Olanzapine Sales, Revenue, Price and Gross Margin (2020-2025)
  13.6.4 Par Pharmaceutical Main Business Overview
  13.6.5 Par Pharmaceutical Latest Developments
13.7 Aurobindo Pharma
  13.7.1 Aurobindo Pharma Company Information
  13.7.2 Aurobindo Pharma Olanzapine Product Portfolios and Specifications
  13.7.3 Aurobindo Pharma Olanzapine Sales, Revenue, Price and Gross Margin (2020-2025)
  13.7.4 Aurobindo Pharma Main Business Overview
  13.7.5 Aurobindo Pharma Latest Developments
13.8 Torrent Pharmaceuticals
  13.8.1 Torrent Pharmaceuticals Company Information
  13.8.2 Torrent Pharmaceuticals Olanzapine Product Portfolios and Specifications
  13.8.3 Torrent Pharmaceuticals Olanzapine Sales, Revenue, Price and Gross Margin (2020-2025)
  13.8.4 Torrent Pharmaceuticals Main Business Overview
  13.8.5 Torrent Pharmaceuticals Latest Developments
13.9 Jubilant Lifesciences
  13.9.1 Jubilant Lifesciences Company Information
  13.9.2 Jubilant Lifesciences Olanzapine Product Portfolios and Specifications
  13.9.3 Jubilant Lifesciences Olanzapine Sales, Revenue, Price and Gross Margin (2020-2025)
  13.9.4 Jubilant Lifesciences Main Business Overview
  13.9.5 Jubilant Lifesciences Latest Developments
13.10 Sun Pharmaceutical
  13.10.1 Sun Pharmaceutical Company Information
  13.10.2 Sun Pharmaceutical Olanzapine Product Portfolios and Specifications
  13.10.3 Sun Pharmaceutical Olanzapine Sales, Revenue, Price and Gross Margin (2020-2025)
  13.10.4 Sun Pharmaceutical Main Business Overview
  13.10.5 Sun Pharmaceutical Latest Developments
13.11 Sandoz
  13.11.1 Sandoz Company Information
  13.11.2 Sandoz Olanzapine Product Portfolios and Specifications
  13.11.3 Sandoz Olanzapine Sales, Revenue, Price and Gross Margin (2020-2025)
  13.11.4 Sandoz Main Business Overview
  13.11.5 Sandoz Latest Developments
13.12 Hansoh Pharmaceutical
  13.12.1 Hansoh Pharmaceutical Company Information
  13.12.2 Hansoh Pharmaceutical Olanzapine Product Portfolios and Specifications
  13.12.3 Hansoh Pharmaceutical Olanzapine Sales, Revenue, Price and Gross Margin (2020-2025)
  13.12.4 Hansoh Pharmaceutical Main Business Overview
  13.12.5 Hansoh Pharmaceutical Latest Developments
13.13 WATSON Pharmaceuticals(Changzhou)
  13.13.1 WATSON Pharmaceuticals(Changzhou) Company Information
  13.13.2 WATSON Pharmaceuticals(Changzhou) Olanzapine Product Portfolios and Specifications
  13.13.3 WATSON Pharmaceuticals(Changzhou) Olanzapine Sales, Revenue, Price and Gross Margin (2020-2025)
  13.13.4 WATSON Pharmaceuticals(Changzhou) Main Business Overview
  13.13.5 WATSON Pharmaceuticals(Changzhou) Latest Developments
13.14 Zhejiang Langhua Pharmaceuticals
  13.14.1 Zhejiang Langhua Pharmaceuticals Company Information
  13.14.2 Zhejiang Langhua Pharmaceuticals Olanzapine Product Portfolios and Specifications
  13.14.3 Zhejiang Langhua Pharmaceuticals Olanzapine Sales, Revenue, Price and Gross Margin (2020-2025)
  13.14.4 Zhejiang Langhua Pharmaceuticals Main Business Overview
  13.14.5 Zhejiang Langhua Pharmaceuticals Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION


LIST OFTABLES

Table 1. Olanzapine Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Olanzapine Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Patent
Table 4. Major Players of Generics
Table 5. Global Olanzapine Sales byType (2020-2025) & (Kg)
Table 6. Global Olanzapine Sales Market Share byType (2020-2025)
Table 7. Global Olanzapine Revenue byType (2020-2025) & ($ million)
Table 8. Global Olanzapine Revenue Market Share byType (2020-2025)
Table 9. Global Olanzapine Sale Price byType (2020-2025) & (USD/Kg)
Table 10. Global Olanzapine Sale by Application (2020-2025) & (Kg)
Table 11. Global Olanzapine Sale Market Share by Application (2020-2025)
Table 12. Global Olanzapine Revenue by Application (2020-2025) & ($ million)
Table 13. Global Olanzapine Revenue Market Share by Application (2020-2025)
Table 14. Global Olanzapine Sale Price by Application (2020-2025) & (USD/Kg)
Table 15. Global Olanzapine Sales by Company (2020-2025) & (Kg)
Table 16. Global Olanzapine Sales Market Share by Company (2020-2025)
Table 17. Global Olanzapine Revenue by Company (2020-2025) & ($ millions)
Table 18. Global Olanzapine Revenue Market Share by Company (2020-2025)
Table 19. Global Olanzapine Sale Price by Company (2020-2025) & (USD/Kg)
Table 20. Key Manufacturers Olanzapine Producing Area Distribution and Sales Area
Table 21. Players Olanzapine Products Offered
Table 22. Olanzapine Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Olanzapine Sales by Geographic Region (2020-2025) & (Kg)
Table 26. Global Olanzapine Sales Market Share Geographic Region (2020-2025)
Table 27. Global Olanzapine Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global Olanzapine Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global Olanzapine Sales by Country/Region (2020-2025) & (Kg)
Table 30. Global Olanzapine Sales Market Share by Country/Region (2020-2025)
Table 31. Global Olanzapine Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global Olanzapine Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas Olanzapine Sales by Country (2020-2025) & (Kg)
Table 34. Americas Olanzapine Sales Market Share by Country (2020-2025)
Table 35. Americas Olanzapine Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas Olanzapine Sales byType (2020-2025) & (Kg)
Table 37. Americas Olanzapine Sales by Application (2020-2025) & (Kg)
Table 38. APAC Olanzapine Sales by Region (2020-2025) & (Kg)
Table 39. APAC Olanzapine Sales Market Share by Region (2020-2025)
Table 40. APAC Olanzapine Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC Olanzapine Sales byType (2020-2025) & (Kg)
Table 42. APAC Olanzapine Sales by Application (2020-2025) & (Kg)
Table 43. Europe Olanzapine Sales by Country (2020-2025) & (Kg)
Table 44. Europe Olanzapine Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe Olanzapine Sales byType (2020-2025) & (Kg)
Table 46. Europe Olanzapine Sales by Application (2020-2025) & (Kg)
Table 47. Middle East & Africa Olanzapine Sales by Country (2020-2025) & (Kg)
Table 48. Middle East & Africa Olanzapine Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa Olanzapine Sales byType (2020-2025) & (Kg)
Table 50. Middle East & Africa Olanzapine Sales by Application (2020-2025) & (Kg)
Table 51. Key Market Drivers & Growth Opportunities of Olanzapine
Table 52. Key Market Challenges & Risks of Olanzapine
Table 53. Key IndustryTrends of Olanzapine
Table 54. Olanzapine Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Olanzapine Distributors List
Table 57. Olanzapine Customer List
Table 58. Global Olanzapine SalesForecast by Region (2026-2031) & (Kg)
Table 59. Global Olanzapine RevenueForecast by Region (2026-2031) & ($ millions)
Table 60. Americas Olanzapine SalesForecast by Country (2026-2031) & (Kg)
Table 61. Americas Olanzapine Annual RevenueForecast by Country (2026-2031) & ($ millions)
Table 62. APAC Olanzapine SalesForecast by Region (2026-2031) & (Kg)
Table 63. APAC Olanzapine Annual RevenueForecast by Region (2026-2031) & ($ millions)
Table 64. Europe Olanzapine SalesForecast by Country (2026-2031) & (Kg)
Table 65. Europe Olanzapine RevenueForecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa Olanzapine SalesForecast by Country (2026-2031) & (Kg)
Table 67. Middle East & Africa Olanzapine RevenueForecast by Country (2026-2031) & ($ millions)
Table 68. Global Olanzapine SalesForecast byType (2026-2031) & (Kg)
Table 69. Global Olanzapine RevenueForecast byType (2026-2031) & ($ millions)
Table 70. Global Olanzapine SalesForecast by Application (2026-2031) & (Kg)
Table 71. Global Olanzapine RevenueForecast by Application (2026-2031) & ($ millions)
Table 72. Lilly Basic Information, Olanzapine Manufacturing Base, Sales Area and Its Competitors
Table 73. Lilly Olanzapine Product Portfolios and Specifications
Table 74. Lilly Olanzapine Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 75. Lilly Main Business
Table 76. Lilly Latest Developments
Table 77.Teva Pharmaceutical Basic Information, Olanzapine Manufacturing Base, Sales Area and Its Competitors
Table 78.Teva Pharmaceutical Olanzapine Product Portfolios and Specifications
Table 79.Teva Pharmaceutical Olanzapine Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 80.Teva Pharmaceutical Main Business
Table 81.Teva Pharmaceutical Latest Developments
Table 82. Dr. Reddy's Laboratories Basic Information, Olanzapine Manufacturing Base, Sales Area and Its Competitors
Table 83. Dr. Reddy's Laboratories Olanzapine Product Portfolios and Specifications
Table 84. Dr. Reddy's Laboratories Olanzapine Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 85. Dr. Reddy's Laboratories Main Business
Table 86. Dr. Reddy's Laboratories Latest Developments
Table 87. Apotex Inc. Basic Information, Olanzapine Manufacturing Base, Sales Area and Its Competitors
Table 88. Apotex Inc. Olanzapine Product Portfolios and Specifications
Table 89. Apotex Inc. Olanzapine Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 90. Apotex Inc. Main Business
Table 91. Apotex Inc. Latest Developments
Table 92. Mylan Pharmaceuticals Basic Information, Olanzapine Manufacturing Base, Sales Area and Its Competitors
Table 93. Mylan Pharmaceuticals Olanzapine Product Portfolios and Specifications
Table 94. Mylan Pharmaceuticals Olanzapine Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 95. Mylan Pharmaceuticals Main Business
Table 96. Mylan Pharmaceuticals Latest Developments
Table 97. Par Pharmaceutical Basic Information, Olanzapine Manufacturing Base, Sales Area and Its Competitors
Table 98. Par Pharmaceutical Olanzapine Product Portfolios and Specifications
Table 99. Par Pharmaceutical Olanzapine Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 100. Par Pharmaceutical Main Business
Table 101. Par Pharmaceutical Latest Developments
Table 102. Aurobindo Pharma Basic Information, Olanzapine Manufacturing Base, Sales Area and Its Competitors
Table 103. Aurobindo Pharma Olanzapine Product Portfolios and Specifications
Table 104. Aurobindo Pharma Olanzapine Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 105. Aurobindo Pharma Main Business
Table 106. Aurobindo Pharma Latest Developments
Table 107.Torrent Pharmaceuticals Basic Information, Olanzapine Manufacturing Base, Sales Area and Its Competitors
Table 108.Torrent Pharmaceuticals Olanzapine Product Portfolios and Specifications
Table 109.Torrent Pharmaceuticals Olanzapine Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 110.Torrent Pharmaceuticals Main Business
Table 111.Torrent Pharmaceuticals Latest Developments
Table 112. Jubilant Lifesciences Basic Information, Olanzapine Manufacturing Base, Sales Area and Its Competitors
Table 113. Jubilant Lifesciences Olanzapine Product Portfolios and Specifications
Table 114. Jubilant Lifesciences Olanzapine Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 115. Jubilant Lifesciences Main Business
Table 116. Jubilant Lifesciences Latest Developments
Table 117. Sun Pharmaceutical Basic Information, Olanzapine Manufacturing Base, Sales Area and Its Competitors
Table 118. Sun Pharmaceutical Olanzapine Product Portfolios and Specifications
Table 119. Sun Pharmaceutical Olanzapine Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 120. Sun Pharmaceutical Main Business
Table 121. Sun Pharmaceutical Latest Developments
Table 122. Sandoz Basic Information, Olanzapine Manufacturing Base, Sales Area and Its Competitors
Table 123. Sandoz Olanzapine Product Portfolios and Specifications
Table 124. Sandoz Olanzapine Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 125. Sandoz Main Business
Table 126. Sandoz Latest Developments
Table 127. Hansoh Pharmaceutical Basic Information, Olanzapine Manufacturing Base, Sales Area and Its Competitors
Table 128. Hansoh Pharmaceutical Olanzapine Product Portfolios and Specifications
Table 129. Hansoh Pharmaceutical Olanzapine Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 130. Hansoh Pharmaceutical Main Business
Table 131. Hansoh Pharmaceutical Latest Developments
Table 132. WATSON Pharmaceuticals(Changzhou) Basic Information, Olanzapine Manufacturing Base, Sales Area and Its Competitors
Table 133. WATSON Pharmaceuticals(Changzhou) Olanzapine Product Portfolios and Specifications
Table 134. WATSON Pharmaceuticals(Changzhou) Olanzapine Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 135. WATSON Pharmaceuticals(Changzhou) Main Business
Table 136. WATSON Pharmaceuticals(Changzhou) Latest Developments
Table 137. Zhejiang Langhua Pharmaceuticals Basic Information, Olanzapine Manufacturing Base, Sales Area and Its Competitors
Table 138. Zhejiang Langhua Pharmaceuticals Olanzapine Product Portfolios and Specifications
Table 139. Zhejiang Langhua Pharmaceuticals Olanzapine Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 140. Zhejiang Langhua Pharmaceuticals Main Business
Table 141. Zhejiang Langhua Pharmaceuticals Latest Developments



LIST OFFIGURES

Figure 1. Picture of Olanzapine
Figure 2. Olanzapine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Olanzapine Sales Growth Rate 2020-2031 (Kg)
Figure 7. Global Olanzapine Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Olanzapine Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Olanzapine Sales Market Share by Country/Region (2024)
Figure 10. Olanzapine Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Patent
Figure 12. Product Picture of Generics
Figure 13. Global Olanzapine Sales Market Share byType in 2025
Figure 14. Global Olanzapine Revenue Market Share byType (2020-2025)
Figure 15. Olanzapine Consumed in OlanzapineTablets
Figure 16. Global Olanzapine Market: OlanzapineTablets (2020-2025) & (Kg)
Figure 17. Olanzapine Consumed in Others
Figure 18. Global Olanzapine Market: Others (2020-2025) & (Kg)
Figure 19. Global Olanzapine Sale Market Share by Application (2024)
Figure 20. Global Olanzapine Revenue Market Share by Application in 2025
Figure 21. Olanzapine Sales by Company in 2025 (Kg)
Figure 22. Global Olanzapine Sales Market Share by Company in 2025
Figure 23. Olanzapine Revenue by Company in 2025 ($ millions)
Figure 24. Global Olanzapine Revenue Market Share by Company in 2025
Figure 25. Global Olanzapine Sales Market Share by Geographic Region (2020-2025)
Figure 26. Global Olanzapine Revenue Market Share by Geographic Region in 2025
Figure 27. Americas Olanzapine Sales 2020-2025 (Kg)
Figure 28. Americas Olanzapine Revenue 2020-2025 ($ millions)
Figure 29. APAC Olanzapine Sales 2020-2025 (Kg)
Figure 30. APAC Olanzapine Revenue 2020-2025 ($ millions)
Figure 31. Europe Olanzapine Sales 2020-2025 (Kg)
Figure 32. Europe Olanzapine Revenue 2020-2025 ($ millions)
Figure 33. Middle East & Africa Olanzapine Sales 2020-2025 (Kg)
Figure 34. Middle East & Africa Olanzapine Revenue 2020-2025 ($ millions)
Figure 35. Americas Olanzapine Sales Market Share by Country in 2025
Figure 36. Americas Olanzapine Revenue Market Share by Country (2020-2025)
Figure 37. Americas Olanzapine Sales Market Share byType (2020-2025)
Figure 38. Americas Olanzapine Sales Market Share by Application (2020-2025)
Figure 39. United States Olanzapine Revenue Growth 2020-2025 ($ millions)
Figure 40. Canada Olanzapine Revenue Growth 2020-2025 ($ millions)
Figure 41. Mexico Olanzapine Revenue Growth 2020-2025 ($ millions)
Figure 42. Brazil Olanzapine Revenue Growth 2020-2025 ($ millions)
Figure 43. APAC Olanzapine Sales Market Share by Region in 2025
Figure 44. APAC Olanzapine Revenue Market Share by Region (2020-2025)
Figure 45. APAC Olanzapine Sales Market Share byType (2020-2025)
Figure 46. APAC Olanzapine Sales Market Share by Application (2020-2025)
Figure 47. China Olanzapine Revenue Growth 2020-2025 ($ millions)
Figure 48. Japan Olanzapine Revenue Growth 2020-2025 ($ millions)
Figure 49. South Korea Olanzapine Revenue Growth 2020-2025 ($ millions)
Figure 50. Southeast Asia Olanzapine Revenue Growth 2020-2025 ($ millions)
Figure 51. India Olanzapine Revenue Growth 2020-2025 ($ millions)
Figure 52. Australia Olanzapine Revenue Growth 2020-2025 ($ millions)
Figure 53. ChinaTaiwan Olanzapine Revenue Growth 2020-2025 ($ millions)
Figure 54. Europe Olanzapine Sales Market Share by Country in 2025
Figure 55. Europe Olanzapine Revenue Market Share by Country (2020-2025)
Figure 56. Europe Olanzapine Sales Market Share byType (2020-2025)
Figure 57. Europe Olanzapine Sales Market Share by Application (2020-2025)
Figure 58. Germany Olanzapine Revenue Growth 2020-2025 ($ millions)
Figure 59.France Olanzapine Revenue Growth 2020-2025 ($ millions)
Figure 60. UK Olanzapine Revenue Growth 2020-2025 ($ millions)
Figure 61. Italy Olanzapine Revenue Growth 2020-2025 ($ millions)
Figure 62. Russia Olanzapine Revenue Growth 2020-2025 ($ millions)
Figure 63. Middle East & Africa Olanzapine Sales Market Share by Country (2020-2025)
Figure 64. Middle East & Africa Olanzapine Sales Market Share byType (2020-2025)
Figure 65. Middle East & Africa Olanzapine Sales Market Share by Application (2020-2025)
Figure 66. Egypt Olanzapine Revenue Growth 2020-2025 ($ millions)
Figure 67. South Africa Olanzapine Revenue Growth 2020-2025 ($ millions)
Figure 68. Israel Olanzapine Revenue Growth 2020-2025 ($ millions)
Figure 69.Turkey Olanzapine Revenue Growth 2020-2025 ($ millions)
Figure 70. GCC Countries Olanzapine Revenue Growth 2020-2025 ($ millions)
Figure 71. Manufacturing Cost Structure Analysis of Olanzapine in 2025
Figure 72. Manufacturing Process Analysis of Olanzapine
Figure 73. Industry Chain Structure of Olanzapine
Figure 74. Channels of Distribution
Figure 75. Global Olanzapine Sales MarketForecast by Region (2026-2031)
Figure 76. Global Olanzapine Revenue Market ShareForecast by Region (2026-2031)
Figure 77. Global Olanzapine Sales Market ShareForecast byType (2026-2031)
Figure 78. Global Olanzapine Revenue Market ShareForecast byType (2026-2031)
Figure 79. Global Olanzapine Sales Market ShareForecast by Application (2026-2031)
Figure 80. Global Olanzapine Revenue Market ShareForecast by Application (2026-2031)


More Publications

Global Livestock Dewormers Market Growth 2023-2029 US$ 3,660.00 March 2023 104 pages
Global Vegan Collagen Market Growth 2025-2031 US$ 3,660.00 December 2025 124 pages